Triage of Persons With Tuberculosis Symptoms Using Artificial Intelligence–Based Chest Radiograph Interpretation: A Cost-Effectiveness Analysis

Abstract

Background In settings without access to rapid expert radiographic interpretation, artificial intelligence (AI)–based chest radiograph (CXR) analysis can triage persons presenting with possible tuberculosis (TB) symptoms, to identify those who require additional microbiological testing. However, there is limited evidence of the cost-effectiveness of this technology as a triage tool. Methods A decision analysis model was developed to evaluate the cost-effectiveness of triage strategies with AI-based CXR analysis for patients presenting with symptoms suggestive of pulmonary TB in Karachi, Pakistan. These strategies were compared to the current standard of care using microbiological testing with smear microscopy or GeneXpert, without prior triage. Positive triage CXRs were considered to improve referral success for microbiologic testing, from 91% to 100% for eligible persons. Software diagnostic accuracy was based on a prospective field study in Karachi. Other inputs were obtained from the Pakistan TB Program. The analysis was conducted from the healthcare provider perspective, and costs were expressed in 2020 US dollars. Results Compared to upfront smear microscopy for all persons with presumptive TB, triage strategies with AI-based CXR analysis were projected to lower costs by 19%, from $23233 per 1000 persons, and avert 3%–4% disability-adjusted life-years (DALYs), from 372 DALYs. Compared to upfront GeneXpert, AI-based triage strategies lowered projected costs by 37%, from $34346 and averted 4% additional DALYs, from 369 DALYs. Reinforced follow-up for persons with positive triage CXRs but negative microbiologic tests was particularly cost-effective. Conclusions In lower-resource settings, the addition of AI-based CXR triage before microbiologic testing for persons with possible TB symptoms can reduce costs, avert additional DALYs, and improve TB detection.

The rise of artificial intelligence reading of chest X-rays for enhanced TB diagnosis and elimination

“…For the first full economic evaluation, researchers developed a decision-analysis model to assess the cost-effectiveness of CAD as a triage tool for patients presenting with TB symptoms in a low-income, high TB incidence population in Pakistan. 24 Compared to the status quo of smear microscopy and GeneXpert, with no prior triage, CAD as a triage tool was projected to reduce costs by respectively 19% and 37% while averting 3–4% additional disability-adjusted life-years. An active case-finding intervention using mobile CXR units equipped with CAD and Xpert testing was found to be cost-effective in Zambia, especially in populations with high HIV and TB mortality.…”

Diagnostic Accuracy of Computer-Aided Detection During Active Case Finding for Pulmonary Tuberculosis in Africa: A Systematic Review and Meta-analysis

“…Cost and resource demand are high, especially during large-scale prevalence surveys, and performing microbiological testing on all participants is often infeasible. Therefore, tools such as digital chest radiography and CAD offer a potential solution by being an accurate screening/triage test, while also being cost-effective [ 37 , 38 ]. However, a proportion of participants who do not undergo microbiological diagnostic testing, for example, those who are asymptomatic or had a normal-appearing chest x-ray, may in fact have TB and be potentially missed.…”

Tuberculosis in the Russian Federation: Prognosis and Epidemiological Models in a Situation After the COVID-19 Pandemic

“…At the same time, some studies have shown the effectiveness of chest X-ray only after preliminary sputum smear microscopy, which increases the economic benefits of screening by 19% and the effectiveness of activities, and prevents additional economic losses by 37% [ 32 ].…”